# PREGABALIN
> **ANDA202269** · Abbreviated New Drug Application (Generic) · Sponsor: NOVEL LABS INC · Approved 2014-10-23
## Drug
- **FDA Application Number:** ANDA202269
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** PREGABALIN
- **Generic name:** Pregabalin
- **Active ingredients:** PREGABALIN
- **Dosage form:** SOLUTION
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** NOVEL LABS INC
- **First approval:** 2014-10-23
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202269)
---
*MORVS · CC0 1.0*